Market Place
Sourcing Support
Kwality Pharma Gets Approval For Leuprorelin Acetate Injection
07 Nov 2024 //
INDIANPHARMAPOST
Foresee Receives +ve Recommendation to Continue the Ph 3 Trial of Leuprolide
01 Apr 2024 //
PR NEWSWIRE
Zydus inks licensing agreement with Daewoong for leuprolide in the US
12 Dec 2023 //
INDIAN PHARMA POST
Enforcement Report - Week of October 4, 2023
04 Oct 2023 //
FDA
XTANDI® plus Leuprolide Reduced Risk of Metastasis by 58% NMHS Prostate Cancer
29 Apr 2023 //
PR NEWSWIRE
Astellas, Pfizer eye new prostate cancer use for Xtandi
18 Mar 2023 //
FIERCE PHARMA
Peptron`s PT105 established the bioequivalence with Takeda`s Leuplin
28 Nov 2022 //
PRNEWSWIRE
Amneal Receives FDA Approval for Leuprolide Acetate Injection
02 Nov 2022 //
BUSINESSWIRE
Amneal`s Generic Leuprolide Acetate Receives Approval in the U.S.
28 Oct 2022 //
FDA
Eugia Pharma Generic Leuprolide Acetate Receives Approval in the U.S
06 Jun 2022 //
FDA
Accord Bio, Foresee Pharma Partner to Launch CAMCEVI Injection Emulsion
04 Apr 2022 //
PRNEWSWIRE
Takeda guilty of breach of contract in partnership with AbbVie
24 Sep 2021 //
FIERCEPHARMA
In AbbVie suit, court finds it can`t force Takeda to supply drug
09 Sep 2021 //
FIERCEPHARMA
Tolmar Publishes FENSOLVI ® (leuprolide acetate) for Injectable Suspension
24 Nov 2020 //
PRNEWSWIRE
Tolmar Affirms Supply of FENSOLVI® (leuprolide acetate) for Pediatric Patients
18 Aug 2020 //
PRNEWSWIRE
Tolmar Affirms Full Supply of Eligard® for Injectable Suspension Palliative
10 Aug 2020 //
PRNEWSWIRE
Takeda hustles to supply cancer med after FDA warning
07 Aug 2020 //
FIERCE PHARMA
Early Treatment Linked to Reduced Joint Damage in Young Adults Hemophilia A
03 Jun 2020 //
PRNEWSWIRE
Leuprorelin depot medicines: PRAC recommends new measures to avoid errors
15 May 2020 //
EMA
Myovant`s oral prostate cancer drug matches incumbent in phase 3
20 Nov 2019 //
FIERCE BIOTECH
Myovant`s oral prostate cancer drug matches incumbent in phase 3
20 Oct 2019 //
FIERCE BIOTECH
Myovant`s oral prostate cancer drug matches incumbent in phase 3
20 Oct 2019 //
FIERCE BIOTECH
SU2C to support clinical trials in breast and prostate cancers
18 Sep 2019 //
CLINEICALTRIALSARENA
Determination That LUPRON (Leuprolide Acetate) Injection
30 May 2019 //
FEDERAL REGISTER
Foresee Pharmaceuticals Enters License Agreement with Accord Healthcare
11 Feb 2019 //
PR NEWSWIRE
Enteris BioPharma Announces Positive Results Ph2a of Ovarest®
26 Jun 2018 //
PR NEWSWIRE
Enforcement Report - Week of May 16, 2018
16 May 2018 //
FDA
Enteris BioPharma Announces Completion of in Expanded Ph2a CTRL of Ovarest®
30 Apr 2018 //
PR NEWSWIRE
EDQM had granted a CEP for Leuprorelin
03 Oct 2017 //
PRESS RELEASE
Drug used to halt puberty in children may cause lasting health problems
03 Feb 2017 //
STAT
Enteris BioPharma Signs Oral Diabetes Pact with Sanofi
24 Jan 2017 //
FIERCE BIOTECH
Allergan plans to file oral uterine fibroid drug in US by year-end
17 Jan 2017 //
PMLIVE
Myovant Bumps IPO to $218M with Pfizer, BB Biotech Aid
28 Oct 2016 //
FIERCE BIOTECH
Drug shortages become issue in Teva and Mylan hook-up
30 Apr 2015 //
FIERCE PHARMA MANUFACTURING
